Background Asthma is a chronic inflammatory disorder in which Th2, Th1 and suppressive T cells (Tregs) play a role. The transcription factor FoxP3 plays a role in Treg differentiation while T-bet is important for Th1 and GATA-3 for Th2 differentiation from naïve T cells. Recent data show that age-related deregulation of Treg cells is a mechanism of senescence affecting several chronic diseases. It is crucial to understand the behaviour of these cell populations in asthma for elderly patients. Objective To evaluate FoxP3, GATA-3 and T-bet gene expression under basal conditions and after in vitro activation in a group of elderly asthmatic compared with age-matched healthy individuals. Methods Thirty-two elderly asthmatics and 17 healthy elderly individuals were selected. Serum total IgE was measured, and peripheral blood mononuclear cells (PBMCs) were isolated and stimulated in vitro with anti-CD3/anti-CD28, followed by mRNA isolation. After reverse transcription, real-time quantitative PCR was performed and relative quantification was determined 2 ÀDDC t (2 ÀDDCt method).
Introduction
Asthma is an airway chronic inflammatory disorder characterized by a decline in pulmonary function that is correlated with age, disease duration and severity. As more than 300 million individuals suffer from this disease and the prevalence is increasing [1] , it is an important field of study. It is often reported in children but affects all age groups including the elderly [1, 2] . In this age group, this pathology represents a growing clinical problem, with an estimated prevalence between 6% and 14%, and is characterized by the same clinical features of the younger population [3] [4] [5] [6] .
In asthmatic airways, Th2 cells are activated and release several cytokines that regulate IgE production and inflammatory cell recruitment, such as eosinophils [7] . Several studies addressed the role of Treg in allergic diseases preventing disease development by suppressing their activity such as Th2 cytokine production [8, 9] . Treg has been defined by markers including CD4, CD25, and more recently, a member of the forkhead box transcription factor -FoxP3 -was set as a more specific marker and is also important for their development and function [10] . These cells have a suppressive effect on inflammatory responses and are recognized as a major cell subset maintaining peripheral immune tolerance [11] [12] [13] . FoxP3 is crucial for naïve T cell differentiation towards the Treg phenotype and is considered as the main regulator of CD25 1 Treg cell activation [12, 14] . These cells prevent both activation and effector function of autoreactive T cells that escaped to other mechanisms of tolerance [13] and they are assumed to control not only pathogenic Th2 cells but also Th1 cells. Although Th2 cells have been the most frequently studied T cells in asthma, there is evidence that Th1 cells are also involved in the development of this disease. Moreover, Th2 and Th1 cells are regulated and committed by the transcription factors GATA-3 and T-bet, respectively.
Treg cells are essential in the regulation of inflammatory diseases and more data are needed to clarify their role in allergic diseases in addition to the established role of Th1 and Th2 cells. During the ageing process, the immunoinflammatory response is modified and it is assumed that in this age group peripheral blood (PB) Treg cells are increased [5, 15] .
The aim of this study was to evaluate fold increase of FoxP3, GATA-3 and T-bet mRNA expression, in peripheral blood mononuclear cells (PBMCs), under basal conditions and following in vitro activation with anti-CD3/anti-CD28, considering the ability of generated signals to establish reciprocal modulation, in elderly asthmatic patients. This study intends to clarify whether the decrease on Treg cells reported in adult asthma persists in the elderly aged groups despite the increased levels of Treg cells inherent to the immunosenescence process.
Material and methods

Subjects and blood samples
This study enrolled 32 elderly (X65 years) (mean age 72AE5 years) patients who had been suffering from asthma for 430 years, after informed consent. All patients had early-onset asthma starting at 26AE11 years. The diagnosis and severity of asthma were defined according to guidelines of the Global Initiative for Asthma [1] . All patients had asthma, controlled by using 250-750 mg of beclometasone dipropionate daily and short-acting b 2 -agonists as needed. All other anti-asthmatic drugs were withdrawn at least 4 weeks before the study. The control group consisted of healthy non-allergic elderly volunteers (n = 17) older than 65 years (mean age 78AE7 years). The absence of allergic diseases and asthma in this control group was confirmed on the basis of a detailed clinical questionnaire and skin prick tests (SPT).
Smoking subjects and patients with recent (last 6 weeks) infectious diseases, auto-immune diseases and neoplasic diseases were excluded.
Lung function was assessed by spirometry (Vitalograph Compact, Ennis, Ireland) at least 6 h after the last dose of any bronchodilator. Predicted values of forced expiratory volume in 1 s (FEV 1 ) were measured according to Knudson et al. [16] . Fractional concentration of exhaled nitric oxide (FENO) was measured using a NioxMino collection device (Aerocrine, Solna, Sweden) with an expiratory flux of 50 mL/s during 6 s, according to the American Thoracic Society recommendations [17] . All the individuals studied were subjected to SPT to 20 common aeroallergens (ALK-ABELLO/Lancetter-tames Hollister Stier). Histamine dihydrochloride was used as a positive control (10 mg/mL) and saline solution used as a negative control. Subjects were classified as allergic with one positive test associated with clinical symptoms and as atopic if they had at least one positive SPT.
The entire study was performed during January/February, outside the grass, weed and tree pollen season. In this period, house dust mites' growth and dispersion were also restricted, which allowed a low allergen exposure and clinical, stabilized condition.
PB was collected into serum and lithium-heparin separating tubes.
IgE and eosinophils' determination
Serum total IgE was measured using a commercial kit (Coat-A-Count s Total-IgE IRMA, DPC s , Los Angeles, CA, USA) based on an immune-radiometric assay of the solid phase and according to the manufacturer's guidelines. Concentration was determined by comparison with provided calibrators. Haemograms were performed in order to count blood eosinophils.
PBMC isolation and in vitro T cell stimulation
PBMCs were separated by gradient density using Biocoll (1.077 g/mL) (Biochrom AG, Berlin, Germany) from lithium-heparin tubes and 3Â10 6 PBMCs per well (24-well plate) were stimulated in vitro (48 h, 37 1C and 5% CO 2 ), in an AIM-V serum-free medium (Gibco Brl, Invitrogen, Carlsbad, CA, USA) with 1 mg/mL of LPS-free anti-CD3/anti-CD28 (granted from Swiss Institute of Allergy and Asthma Research, SIAF, Davos, Switzerland), also setting a control without antibodies (basal condition). 
Real-time PCR
cDNA was amplified using Sybergreen mix according to the manufacturer's recommendations, on a 96-well PCR plate, and run on an IQ5 Real-Time PCR Detection System (all reagents and systems from BioRad). The following sequence of primers was referenced by SIAF: T-bet fwd GATGCGCCA GGAAGTTTCAT, T-bet rev GCACAATCATCTGGGTCACATT; GATA-3 fwd GCGGGCTCTATCACAAAATGA, GATA-3 rev GCTCTCCTGGCTGCAGACAGC; FoxP3 fwd GAAACAGCAC ATTCCCAGAGTTC, FoxP3 rev ATGGCCCAGCGGATGAG; elongation factor-1 (EF-1) fwd CTGAACCATCCAGGCCAAAT, EF-1 rev GCCGTGTGGCAATCCAAT.
Real-time PCR conditions were as follows: stage 1: 2 min at 50 1C; stage 2: 3 min at 95 1C; stage 3: 15 s at 95 1C and 45 s at 60 1C (40 repeats).
The amount of FoxP3, GATA-3 and T-bet mRNA expression was normalized with endogenous control EF-1 (DC t values) and the relative quantification and calculation of range of confidence were performed using the comparative threshold cycle (2 ÀDDC t ) method (relative gene expression), as described by Livak and Schmittgen [18] . All amplifications were carried out at least in duplicate.
Statistical analysis
Statistical analysis was performed using the SPSS 12.0 software package. Data were analysed using either ANOVA (performing the Tukey HSD post hoc tests), Student's t-test (normality test passed with Kolmogorov-Smirnov) or the Mann-Whitney non-parametric test (normality test failed). Pearson correlation analysis was also performed between the variables studied. Significance was defined for P-valueo0.05.
Results
Twenty-two asthmatic patients presented positive SPTs to at least one of the common aeroallergens tested and were classified as allergic. Asthmatics presented normal mean percentual values of FEV 1 (90AE23), and in five individuals, these values were below 60% in accordance with a diagnosis of severe asthma. Within the asthmatic group, six patients presented high FENO values.
Age, sex, lung function, serum total IgE, blood eosinophils and FENO from elderly asthmatic patients and healthy non-allergic non-asthmatic elderly volunteers are summarized in Table 1 . Allergic patients presented higher serum IgE values and blood eosinophil counts and the differences observed between allergic and non-allergic, for serum total IgE, were statistically significant.
The FoxP3 and GATA-3 DC t values under basal conditions were reduced in asthmatic patients when compared with the control group, while the T-bet DC t values were similar in both the groups studied (Fig. 1 ). Comparing the studied groups for FoxP3, GATA-3 and T-bet relative gene expression after in vitro stimulation, higher values (fold increase averageAEstandard deviation) were observed in controls (healthy individuals) than in asthmatic patients (10.2AE6.8 vs. 4.8AE3.8, 2.4AE2.9 vs. 1.7AE0.9 and 3.3AE2.1 vs. 2.1AE1.5, respectively). Asthmatics showed lower relative mRNA expression values of FoxP3 and T-bet. These differences among groups were statistically significant (Po0.05) (Figs 2a, c and d) .
Subdividing the asthmatic group into non-allergic and allergic patients, the main statistically significant differences were once more for FoxP3, with lower and similar relative mRNA expression values in allergics (4.8AE3.0) and non-allergics (4.8AE4.3), contrasting to higher values in healthy individuals (10.2AE6.8) (Po0.05) (Fig. 2b) . However, the GATA-3 and T-bet values were similar without statistical significance when allergic and nonallergic patients were considered and compared with the control group (1.4AE0.8 and 1.8AE1.0 vs. 2.4AE2.9, respectively, for GATA-3; 1.9AE1.5 and 2.2AE1.6 vs. 3.3AE2.1, respectively, for T-bet). Multiple comparisons were performed using ANOVA analysis and differences in P-values40.05 were considered significant. Po0.05. FENO, fractional concentration of exhaled nitric oxide; FEV 1 , forced expiratory volume in the first second; p.p.b., parts per billion; SD, standard deviation.
A positive correlation was found between total IgE and GATA-3 expression with statistical significance (r = 0.382, P = 0.041) in the asthmatic group (Fig. 3a) . On the contrary, there was no correlation for the other transcription factors (FoxP3 and T-bet) with IgE values (Figs 3b and c) or other clinical features (data not shown).
Taking into account that increased levels of IgE production are associated with higher GATA-3 gene expression and lower T-bet gene expression, thus affecting the balance between Th2 and Th1 cells, the T-bet/GATA-3 ratio was also assessed using values after stimulation. When ratios between these investigated genes were analysed, statistical differences were observed between asthmatics and controls for the T-bet/GATA-3 ratio, with lower mean values in the patient group (1.5AE1.3) than in the controls (2.8AE3.3) (P = 0.038) (Fig. 4a) . Considering that the balance between Treg/Th effector cells can also regulate the degree of inflammation in asthma, the Treg/Th2 ratio (FoxP3/GATA-3) was used additionally (Fig. 4b) . Asthmatic patients presented a slightly reduced ratio (5.2AE6.6) when compared with healthy control subjects (8.8AE6.9) (P40.05) (Fig. 4b) .
Discussion
This study was carried out to evaluate Th1-, Th2-and Tregrelated lineage-specific gene expression, in long-lasting asthma. Asthmatics tend to demonstrate a decline in FEV1, which is related to the disease's progression, but can also be affected by both genetic and environmental factors [2, 19] . Most of the patients had controlled asthma with lung function and FENO values within the normal range, despite the long disease duration [1] . It was also ensured that the healthy control subjects were free from atopy by performing SPTs despite the absence of symptoms.
Although IgE levels decrease with age, IgE-mediated allergy can affect 75% of elderly asthmatics, suggesting that the Th2 phenotype can still be dominant in this group. Th2 cells and GATA-3 play an important role in allergic inflammation and asthma, and induce IgE production [19] . The asthmatic patients presented high levels of total IgE (Table 1) when SPT was positive. On the contrary, the T-bet gene expression and Th1 pattern, along with the IFN-g production, are usually associated with non-allergic asthmatics and healthy subjects. Although eosinophil infiltration is the main feature of both allergic and non-allergic asthma [7, 19] , it is known that the overproduction of Th2-type cytokines can regulate antigen-induced eosinophil survival, leading to an increase of eosinophils in the allergic patients studied.
The values of GATA-3 gene expression of asthmatics were low under basal conditions and remained low after in vitro stimulation, in contrast to what was expected according to data for younger asthmatic groups who present an increase in GATA-3 expression [20] . The normal process of GATA-3 expression after in vitro stimulation is probably repressed in these patients, who seem to maintain the ability to produce high levels of IgE. The low grade chronic pro-inflammatory status in elderly (inflamm-ageing) probably plays a role in the relative bias towards Th2 immunity reported in senescence affecting both patients and healthy individuals [21] and reducing the differences in GATA-3 expression between the two groups analysed both in basal and in activated states. Nevertheless, a significant positive correlation was demonstrated between total IgE and GATA-3 expression (r = 0.382, P = 0.041) (Figs 1, 2c and 3a) . This finding emphasizes the close relationship between IgE and GATA-3 expression and underlines the importance of this transcription factor as an inductor of IL4/IgE production even in elderly patients. A statistical difference between asthmatics and controls for the T-bet/GATA-3 ratio (Th1/ Th2 ratio), with lower mean values in the patient group (P = 0.038), was also observed (Fig. 4a) , which also emphasizes the Th2 role in asthma, where these cells are increased [19] . Therefore, the reduced ratio in Treg/Th2 cells observed can also contribute to the persistence of inflammation in long-lasting asthma (Fig. 4b) .
The T-bet values, after in vitro stimulation, were significantly lower in asthmatics when compared with the control group (Fig. 2d) . When considering both allergic and non-allergic groups, the GATA-3 and T-bet values were slightly lower, without statistical significance, when compared with the control groups. The atopic status does not introduce any adjustment in elderly patients. In fact, a decrease in the T-bet values has already been reported in severe asthma associated with airway remodelling affecting younger patients [19, 20] . In spite of this, we should emphasize again that this study was performed in elderly patients and the results should be interpreted considering the changes related to the immunosenescence process. Individuals aged 65 years or over present an age-associated shift towards the Th2 cytokine profile, affecting the typical atopic phenotype. Furthermore, in the elderly, there is a decline in the naïve strains while the sensitized cells become predominant [22] .
T cell activation was induced with anti-CD3/anti-CD28, allowing naïve cells to become activated and to receive signals from other cells, which modulate the expression of T-bet, GATA-3 and FoxP3 genes. Cytokine environments induce a preferential expression of T-bet or GATA-3 and a Th1 or a Th2 dominant response with the release of their cytokines. The reduction of naïve cells in the elderly can explain the impaired development of these two differentiated phenotypes [23] . It should not be ignored that these results could be reinforced hypothetically with the measurement of cytokine like IL-10, IL-4 or IL-13 in the culture supernatant. However, it is now recognized that IL-10 is produced by Th1, Th2, Th17 and Treg cells, while Th1 can produce IL-13 [24] . These recent findings argue for much more flexibility in cytokine production and support the controversial usefulness of their determination [24, 25] . The Foxp3 transcription factor, which can suppress the expression of T-bet and GATA-3 both with a reciprocal role, modulates the immune response when increased [14, 26] . Regulatory cells are supposed to reduce inflammatory responses in several diseases, including asthma. The Treg cell count is low in allergic patients and some therapeutic approaches such as specific immunotherapy can restore their normal values [20, 27] . The increased FoxP3 expression was relevant both in controls and in asthmatics upon activation, even when the two groups of patients were considered (Figs 2a and b) , which might explain the low expression of GATA-3 and T-bet genes (Figs 2c and d) . However, healthy individuals showed significantly higher FoxP3 expression values following activation when compared with asthmatics, as demonstrated previously by Provoost et al. [28] in younger groups. This lower value in asthmatics can provide an explanation for the sustained inflammatory process reported in long-lasting asthma. The underlying chronic inflammatory state in the elderly, with high circulatory pro-inflammatory cytokines, is an additional stimulus for FoxP3 expression in this age group, narrowing the difference between patients and the healthy population.
Recent data demonstrate that the transcription factors for Th1, Th2 and Th17 cells, GATA-3, T-bet, RORgt and FoxP3, respectively, can be co-expressed in some Tregs and exist in vivo [25] . Therefore, through this work, the hypothesis that these Treg cells may become effector cells and participate in normal immune response cannot be excluded. A better understanding of the reciprocal modulation of these three cell phenotypes that control the immunoinflammatory process is key in order to implement future therapeutic approaches.
In conclusion, efforts to improve asthma care and reduce the mortality have evolved from an understanding (c) of the inflammatory basis of asthma. Older people with asthma received low priority regarding research and interventions. Treatments that ameliorate asthma symptoms, including immunotherapy and steroids, which could restore Treg cell function, have deserved a better attention in the scientific community. This study demonstrates that elderly asthmatic patients also present a reduction in Treg cells. In addition, despite their low values of T-bet and GATA-3 expression, the ratio of expression of these two transcription factors shows a Tbet deficiency while GATA-3 expression increases in parallel to the IgE value. An improved understanding of the T cell network involved in long-lasting asthma affecting elderly allows considering new therapeutic approaches directed towards increasing FoxP31Treg and decreasing GATA-3 cells also in elderly patients.
